 |
|
|
Selected Talks
Working at the Frontiers of Law and Science: Applications of the Human Genome
On October 2-3, 2003, the American Bar Association’s Section of Science & Technology Law, the American Medical Association, and the American Association for the Advancement of Science (AAAS), sponsored a conference, Working at the Frontiers of Law and Science: Applications of the Human Genome, at the University of North Carolina at Chapel Hill. The conference included leading scholars and addressed some of the most critical issues related to the ethical and legal aspects associated with human genetics and genomics. The conference organizers and speakers provided AGREE with the opportunity to record the conference in effort to make it accessible to a broader audience. Accordingly, to supplement the AGREE educational modules, one of the sessions with direct relevance to AGREE, "Gene 'Therapies': Anticipated Benefits, Unknown Risks and the Law" is provided here. The session features three experts: Professor Theodore Friedman (University of California, San Diego); Professor Nancy M.P. King (University of North Carolina, Chapel Hill); and Dr. Philip Noguchi (US Food and Drug Administration).
Gene "Therapies": Anticipated Benefits, Unknown Risks, and the Law
- Frontiers of the Law and Science
Theodore Friedmann, MD
- Oversight and Harm-Benefit Information in Gene Transfer Research
Nancy M. P. King, JD
- Risk and Benefits: A Dynamic Balance
Phillip D. Noguchi, MD
The materials on this site and in each module are copyrighted by Duke University and Johns Hopkins University and may not be copied, transmitted, or published without explicit written permission.
© 2003 Duke University Medical Center and Johns Hopkins University. Site Design by MediSpin, Inc. Site hosting by Duke Educational Media Services